Pacira BioSciences
PCRX
PCRX
180 hedge funds and large institutions have $1.35B invested in Pacira BioSciences in 2016 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 66 increasing their positions, 51 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
3% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 37
2% less funds holding
Funds holding: 183 → 180 (-3)
Holders
180
Holding in Top 10
5
Calls
$24.8M
Puts
$16.6M
Top Buyers
| 1 | +$34.8M | |
| 2 | +$26.4M | |
| 3 | +$16.9M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$15.8M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$11.5M |
Top Sellers
| 1 | -$43.3M | |
| 2 | -$36.1M | |
| 3 | -$21.2M | |
| 4 |
HCM
Hoplite Capital Management
New York
|
-$20.4M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$18.9M |